We are live on ! Find out more
CIM

Contravisory Investment Management Portfolio holdings

AUM $566M
1-Year Est. Return 42.93%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+42.93%
3 Year Est. Return
+129.34%
5 Year Est. Return
+198.47%
10 Year Est. Return
+603.03%
AUM
$259M
AUM Growth
+$626K
Cap. Flow
-$11M
Cap. Flow %
-4.26%
Top 10 Hldgs %
27.16%
Holding
343
New
40
Increased
92
Reduced
61
Closed
71

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$5.71M
2
KMB icon
Kimberly-Clark
KMB
+$5.62M
3
RSG icon
Republic Services
RSG
+$5.6M
4
PG icon
Procter & Gamble
PG
+$4.06M
5
DRI icon
Darden Restaurants
DRI
+$3.95M

Top Sells

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$4.87M
2
HPQ icon
HP
HPQ
+$4.75M
3
HUM icon
Humana
HUM
+$4.26M
4
MKL icon
Markel Group
MKL
+$4.11M
5
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$4.1M

Sector Composition

Rank Sector Weight
1 Technology 26.53%
2 Consumer Staples 11.11%
3 Industrials 10.54%
4 Financials 9.14%
5 Healthcare 8.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RLI icon
151
RLI Corp
RLI
$5.89B
$148K 0.06%
3,464
VRE
152
DELISTED
Veris Residential
VRE
$144K 0.06%
6,167
POST icon
153
Post Holdings
POST
$3.57B
$141K 0.05%
2,078
RNR icon
154
RenaissanceRe
RNR
$13.4B
$140K 0.05%
+785
New +$129K
WST icon
155
West Pharmaceutical
WST
$24.9B
$138K 0.05%
1,103
CVX icon
156
Chevron
CVX
$366B
$137K 0.05%
1,100
-13
-1% -$1.57K
ENV
157
DELISTED
ENVESTNET, INC.
ENV
$136K 0.05%
1,983
CUBE icon
158
CubeSmart
CUBE
$9.41B
$130K 0.05%
3,896
DAR icon
159
Darling Ingredients
DAR
$9.44B
$130K 0.05%
6,524
-409
-6% -$8.39K
IWM icon
160
iShares Russell 2000 ETF
IWM
$83B
$129K 0.05%
832
+23
+3% +$3.54K
BHC icon
161
Bausch Health
BHC
$2.34B
$127K 0.05%
5,046
BRC icon
162
Brady Corp
BRC
$4.57B
$126K 0.05%
+2,550
New +$122K
OFIX icon
163
Orthofix Medical
OFIX
$419M
$123K 0.05%
2,319
-164
-7% -$8.72K
THS
164
DELISTED
Treehouse Foods
THS
$123K 0.05%
2,276
CTWS
165
DELISTED
Connecticut Water Service Inc
CTWS
$121K 0.05%
1,732
RGS icon
166
Regis Corp
RGS
$70.2M
$120K 0.05%
362
GWRE icon
167
Guidewire Software
GWRE
$14.2B
$118K 0.05%
1,162
TDC icon
168
Teradata
TDC
$2.55B
$117K 0.05%
3,251
HUBS icon
169
HubSpot
HUBS
$10.5B
$115K 0.04%
+673
New +$117K
RP
170
DELISTED
RealPage, Inc.
RP
$113K 0.04%
+1,917
New +$116K
EPHE icon
171
iShares MSCI Philippines ETF
EPHE
$145M
$111K 0.04%
+3,115
New +$108K
BRK.B icon
172
Berkshire Hathaway Class B
BRK.B
$1.13T
$109K 0.04%
513
+71
+16% +$14.7K
NEU icon
173
NewMarket
NEU
$8.18B
$108K 0.04%
269
WWW icon
174
Wolverine World Wide
WWW
$1.55B
$108K 0.04%
3,906
XLE icon
175
State Street Energy Select Sector SPDR ETF
XLE
$37.7B
$104K 0.04%
3,258
-732
-18% -$23.4K

Similar funds

Contravisory Investment Management's Q2 2019 Portfolio in Review

As of Q2 2019, Contravisory Investment Management held 343 positions worth $259M, up 0.24% from $258M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Contravisory Investment Management withdrew a net $11M in Q2 2019, closing 71 positions and reducing 61 holdings. Its most notable exit was Elevance Health, an estimated $4.87M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Consumer Staples and Industrials.

Against the trend, Contravisory Investment Management opened a new position in AvalonBay Communities worth $3.9M.

  • Contravisory Investment Management's largest Q2 2019 buy was AvalonBay Communities: 19,217 shares worth $3.9M.
  • Contravisory Investment Management added most to Microsoft in Q2 2019, an estimated $5.71M increase.
  • Contravisory Investment Management's biggest Q2 2019 reduction was Universal Health Services, cutting an estimated $588K.
  • Contravisory Investment Management fully exited Elevance Health in Q2 2019, selling an estimated $4.87M.
  • Contravisory Investment Management's ten largest holdings make up 27% of its $259M portfolio in Q2 2019.
  • Contravisory Investment Management opened 40 new positions and closed 71 in Q2 2019.
  • Contravisory Investment Management's portfolio value rose 0.24% quarter-over-quarter to $259M.

Based on Contravisory Investment Management's 13F filing for Q2 2019, filed 9 Jul 2019.